TRPV4 channel activation induces the transition of venous and arterial endothelial cells toward a pro-inflammatory phenotype.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
02 2021
Historique:
received: 13 05 2020
revised: 20 09 2020
accepted: 22 09 2020
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 15 12 2021
Statut: ppublish

Résumé

The Transient Receptor Potential Vanilloid 4 (TRPV4) of endothelial cells contributes to many important functions including the regulation of Ca

Identifiants

pubmed: 33512067
doi: 10.14814/phy2.14613
pmc: PMC7845413
doi:

Substances chimiques

Antigens, CD 0
Cadherins 0
ICAM1 protein, human 0
Inflammation Mediators 0
N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide 0
NF-kappa B 0
Sulfonamides 0
TRPV Cation Channels 0
TRPV4 protein, human 0
cadherin 5 0
Intercellular Adhesion Molecule-1 126547-89-5
Leucine GMW67QNF9C

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14613

Informations de copyright

© 2021 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.

Références

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Sep;40(9):960-6
pubmed: 26408614
Circ Res. 2010 May 14;106(9):1479-88
pubmed: 20360250
J Physiol. 2017 Nov 15;595(22):6869-6885
pubmed: 28949006
Science. 2012 May 4;336(6081):597-601
pubmed: 22556255
Circ Res. 2017 Jan 6;120(1):179-206
pubmed: 28057793
Acta Physiol (Oxf). 2017 Jan;219(1):176-187
pubmed: 27497091
Adv Immunol. 2016;129:25-53
pubmed: 26791857
J Immunol. 2002 Jul 15;169(2):1007-13
pubmed: 12097408
J Thromb Haemost. 2005 Aug;3(8):1815-24
pubmed: 16102048
Physiol Rev. 2016 Jul;96(3):911-73
pubmed: 27252279
Tissue Barriers. 2017 Apr 3;5(2):e1331722
pubmed: 28581893
Exp Cell Res. 2017 Sep 1;358(1):31-38
pubmed: 28602626
Nature. 2003 Jul 24;424(6947):434-8
pubmed: 12879072
Cardiovasc Res. 2015 Aug 1;107(3):331-9
pubmed: 25994174
Circ Res. 2005 Oct 28;97(9):908-15
pubmed: 16179585
Curr Opin Hematol. 2015 Jan;22(1):53-9
pubmed: 25427141
Physiology (Bethesda). 2014 Sep;29(5):343-60
pubmed: 25180264
Biochim Biophys Acta. 2013 Dec;1832(12):2216-31
pubmed: 23994612
Pharmacol Ther. 2008 Jun;118(3):337-51
pubmed: 18508125
Br J Pharmacol. 2018 Jan;175(1):84-99
pubmed: 29053877
Front Mol Neurosci. 2018 Mar 27;11:97
pubmed: 29636662
FASEB J. 2014 Nov;28(11):4677-85
pubmed: 25114176
Pflugers Arch. 2017 Sep;469(9):1121-1134
pubmed: 28456852
Biochem Pharmacol. 2005 Nov 15;70(10):1443-57
pubmed: 16181613
J Clin Invest. 2013 Feb;123(2):540-1
pubmed: 23485580
Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L650-7
pubmed: 19617313
Cell Death Dis. 2015 Jun 04;6:e1775
pubmed: 26043075
Am J Physiol Lung Cell Mol Physiol. 2015 Dec 15;309(12):L1467-77
pubmed: 26453519
Sci Rep. 2016 Aug 11;6:30583
pubmed: 27510430
Physiol Genomics. 2009 Jun 10;38(1):42-53
pubmed: 19351910
Pflugers Arch. 2018 Apr;470(4):633-648
pubmed: 29380056
Brain Res Bull. 2019 Mar;146:143-152
pubmed: 30508606
Circulation. 2007 Mar 13;115(10):1285-95
pubmed: 17353456
Front Cell Neurosci. 2015 Apr 10;9:141
pubmed: 25914628
Physiol Rev. 2015 Apr;95(2):645-90
pubmed: 25834234
Am J Physiol Heart Circ Physiol. 2010 Feb;298(2):H466-76
pubmed: 19966050
J Pharmacol Exp Ther. 2008 Aug;326(2):443-52
pubmed: 18499744
Circ Res. 2006 Oct 27;99(9):988-95
pubmed: 17008604
PLoS One. 2018 Jan 2;13(1):e0190307
pubmed: 29293584
Microcirculation. 2006 Dec;13(8):725-39
pubmed: 17085430
J Cell Mol Med. 2009 Jul;13(7):1211-20
pubmed: 19538472
J Biol Chem. 2002 Jun 28;277(26):23573-81
pubmed: 11950839
Compr Physiol. 2019 Jun 12;9(3):1249-1277
pubmed: 31187891
Exp Cell Res. 2019 Apr 15;377(1-2):56-66
pubmed: 30779919
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):396-401
pubmed: 14691263
Cardiovasc Res. 2008 Dec 1;80(3):445-52
pubmed: 18682435
Front Pharmacol. 2019 Jan 23;10:6
pubmed: 30728775
Biochem Pharmacol. 2015 Nov 1;98(1):78-91
pubmed: 26300057
Prog Neurobiol. 2013 Sep;108:1-20
pubmed: 23851106
Sci Transl Med. 2012 Nov 7;4(159):159ra148
pubmed: 23136043
Biochim Biophys Acta. 2007 Aug;1772(8):907-14
pubmed: 17434294
Circ Res. 2008 Apr 25;102(8):966-74
pubmed: 18323527

Auteurs

Kathia Beddek (K)

INSERM Unité Mixte de Recherche-Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Florent Raffin (F)

Département des Plateformes, unité Analyses Biologiques, IRBA (Institut de Recherche Biomédicale des Armées), Brétigny-sur-Orge, France.

Delphine Borgel (D)

INSERM Unité Mixte de Recherche-Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

François Saller (F)

INSERM Unité Mixte de Recherche-Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Diane Riccobono (D)

Département Effets Biologiques des Rayonnements, unité de Radiobiologie, IRBA (Institut de Recherche Biomédicale des Armées), Brétigny-sur-Orge, France.

Régis Bobe (R)

INSERM Unité Mixte de Recherche-Santé 1176, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

François-Xavier Boittin (FX)

Département Effets Biologiques des Rayonnements, unité de Radiobiologie, IRBA (Institut de Recherche Biomédicale des Armées), Brétigny-sur-Orge, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH